Loading stock data…
SNWV
$15.73-0.64 (-3.91%)
Market ClosedLast close May 1
SANUWAVE Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
SANUWAVE Health, Inc. in the Healthcare sector is trading at $15.73. The stock is currently near its 52-week low of $15.57, remaining 47.1% below its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why SNWV maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$15.73
Potential Downside
362.4%
Whystock Fair Value$-41.27
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus2 analysts
Mean target$43.50+176.5%
Range$40.00 – $47.00
Fundamentals
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$168.10M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
47.71
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-715.87%
Volume
Today's trading volume
114,148
Recent News
Sanuwave Health Inc. (SNWV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Sanuwave Health (SNWV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How The SANUWAVE Health (SNWV) Story Is Shifting After The Latest Price Target Reset
The latest analyst update on SANUWAVE Health centers on a revised price target that is now set $6 lower, even as the fair value anchor holds at $43.5. Analysts who are constructive on the story view this change as a reset that lines expectations up more tightly with current assumptions. More cautious voices see it as a signal to reassess growth and execution risk. As you read on, you will see what this shift could mean for your own view of the stock and how to follow the evolving narrative...
Sanuwave Health (SNWV) Slipped as CMS Dropped the Coverage Limit
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A copy of the letter can be downloaded here. Cedar Grove Capital Management’s Multi-Strategy Composite posted a -23.0% net return since inception, compared to -5.6% for the Russell 2000, -5.9% for the Russell Microcap, and -5.5% for the S&P 500. […]
How The SANUWAVE Health (SNWV) Investment Narrative Is Resetting After A Lower Price Target
SANUWAVE Health’s revised price target, now reduced by $6, has sharpened the focus on what analysts see as a more cautious stance on the story. That reset is tied to updated views on how revenue and profitability might support the valuation investors are prepared to pay, with research teams weighing both potential upside and execution risk. As you read on, you will see what is driving this evolving narrative and how to track the key milestones that could shape it from here. Stay updated as...
How The Reset Price Target Is Rewriting The Story For SANUWAVE Health (SNWV)
SANUWAVE Health is back in focus after an analyst fair value estimate reset from US$55.00 to US$43.50, a reduction of about US$11.50 per share. Bulls view the new US$43.50 target as still leaving room for upside if the company delivers on updated assumptions. Bears see the lower mark as a signal that earlier expectations may have been too optimistic. As you read on, you will see how to track these shifting views and what they might mean for your own research process around SANUWAVE...